Dr. Jörg Taubel will be attending the ESC Congress 2024, held from 30th August to 2nd September in London and online. This event is the world’s leading gathering for cardiovascular professionals, bringing together experts to explore ground breaking research, innovative technologies, and collaborative efforts aimed at reducing the burden of cardiovascular disease.

The ESC Congress 2024 will feature a comprehensive programme, including sessions on the latest advancements in cardiovascular medicine, discussions on clinical practice guidelines, and presentations of cutting-edge research. Attendees will include cardiologists, researchers, healthcare professionals, and industry leaders dedicated to advancing cardiovascular health and improving patient outcomes.

To find out more, click here.

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event